Background: VERVE-101 is an investigational in vivo CRISPR base-editing medicine
designed to alter a single DNA base in the PCSK9 gene, permanently turn off hepatic …

Introduction There is growing evidence to support the use of co‐design in developing
interventions across many disciplines. This scoping review aims to examine how co‐design …

A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal
patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for …

Background Heart failure (HF) is a clinical syndrome with high incidence rates, a substantial
symptom and treatment burden, and a significant risk of readmission within 30 days after …

Background Effectiveness of a non-physician community health-care provider-led intensive
blood pressure intervention on cardiovascular disease has not been established. We aimed …

It is well acknowledged that most of the modifiable risk factors for Cardiovascular Diseases
(CVDs) can be averted through lifestyle modifications beyond medication adherence. This …

Background: Previous medical history strongly contributes to the genesis of intracranial
aneurysms (IA). A possible impact of regular medication on the occurrence of abdominal …

Introduction Adherence to medications for cardiovascular disease and its risk factors is less
than optimal, although greater adherence to medication has been shown to reduce the risk …

The correlation between personality traits and health outcomes of primary prevention has
been examined. However, there is a lack of evidence on the association between the …

Abstract Purpose of Review With growing scientific and public interest in the health benefits
of mindfulness, clinicians increasingly face questions and solicitations for advice from …